DT

Dr. Tracey Rapp

Vice President of Product Development

Novilla Pharmaceuticals

Novilla Pharmaceuticals Pipeline

DrugIndicationPhase
NOV-1776Not explicitly stated (likely General Pain/Joint Inflammation)Phase 2
Pipeline ProgramGoutPre-clinical